Publications
MAPI Group Publications
Evans, C., Chiou, C., Fitzgerald, K., Evans, W., Ferrell, B., Dale, W., et al. “Development of a new patient-reported outcome measure in sarcopenia”. JAMDA . 2011; 226-233.
Brubaker, L., Khullar, V., Piault, E., Evans, C., Bavendam, T., Beach, J., et al. “ Goal attainment scaling in patients with lower urinary tract symptoms: development and pilot testing of the Self-Assessment Goal Achievement (SAGA) questionnaire ”. Intl Urogynecol J. 2011.
Hahn, E.A., Cella, D., Dobrez, D.G., Shiomoto, G., Taylor, S.G., Galvez, A.G., et al. “ Quality of life assessment for low literacy Latinos: a new multimedia program for self-administration ”. J Oncol Manag. 2011; 12:9-12.
Gauchoux, R. “Acceptability Studies: a new way of assessing adherence and understanding its determinants in real life”. PRM Newsletter . (8), 1. 15 April 2011
Mechin, H., Longin, J., Veysseyere, H., Nechadi, S. “Perception of pharmacoepidemiological studies by physicians: the French situation”. PRM Newsletter . (8)3-6. 15 April 2011.
Arbuckle, R., Abetz, L., Durmer, J.S., Ivanenko, A., Owens, J.A., Croenlein, J., et al. “ Development of the Pediatric Restless Legs Syndrome Severity Scale (P-RLS-SS): a patient-reported outcome measure of pediatric RLS symptoms and impact ”. Sleep Med. 2010;11:897-906.
Barsevick, A.M., Cleeland, C.S., Manning, D.C., O'Mara, A.M., Reeve, B.B., Scott, J.A., et al. “ ASCPRO recommendations for the assessment of fatigue as an outcome in clinical trials ”. J Pain Symptom Manage. 2010;39:1086-1099.
Berdeaux, G., Meunier, J., Arnould, B., Viala, M. “ Measuring benefits and patients' satisfaction when glasses are not needed after cataract and presbyopia surgery: scoring and psychometric validation of the Freedom from Glasses Value Scale (FGVS©) ”. BMC Ophthalmol. 2010;10.
Bergman, G., Hochberg, M., Boers, M., Wintfeld, N., Kielhorn, A., Jansen, J. “ Indirect comparison of Tocilizumab and other biologic agents in patients with Rheumatoid Arthritis and inadequate response to disease-modifying antirheumatic drugs ”. Elsevier. 2010;1-17.
Bredart, A., Sultan, S., Regnault, A. “ Patient satisfaction instruments for cancer clinical research or practice ”. Expert Rev Pharmacoecon Outcomes Res. 2010;10:129-141.
Chakravarthy, U., Wong, T.Y., Fletcher, A., Piault, E., Evans, C., Zlateva, G., et al. “ Clinical risk factors for age-related macular degeneration: a systematic review and meta-analysis ”. BMC Ophthalmol. 2010;10:1-13.
Chambers, J., Dennee-Sommers, B., Nothaft, W., Marx, S. “ Systematic literature review on the burden of Illness in Fibromyalgia ”. 2010.
Cochener, B., Fernández-Vega, L., Maurel, F., Meunier, J., Berdeaux, G. “ Spectacle independence and subjective satisfaction of ReSTOR® multifocal intraocular lens after cataract or presbyopia surgery in two European countries ”. Clinical Ophthalmology. 2010;4:81-89.
Crawford, B., Piault, E., Lai, C., Sarzi-Puttini, P. “Assessing sleep in Fibromyalgia: investigation of an alternative scoring method for the Jenkins Sleep Scale based on data from randomised controlled studies”. Clinical and Experimental Rheumatology. 2010;100-109.
Crawford, B., Tanaka, E., Zhu, Y., Burgess, S. “Content and psychometric validity of the Eyelash Satisfaction Questionnaire (ESQ) in China”. 2010.
De Peuter, M.A., Littlewood, K.J., Annemans, L., Largeron, N., Quilici, S. “Cost effectiveness of catch-up programs in human papillomavirus vaccination”. Expert Rev Vaccines. 2010;9:1187-1201.
Dubois, D., Gilet, H., Viala-Danten, M., Tack, J. “Psychometric performance and clinical meaningfulness of the Patient Assessment of Constipation-Quality of Life questionnaire in prucalopride (RESOLOR) trials for chronic constipation”. Neurogastroenterol Motil. 2010;22:54-63.
Gilet, H., Chachuat, A., Viala-Danten, M., Auzière, S., Koltowska-Häggström, M. “Application of the disease-specific Quality of Life Assessment of Growth Hormone Deficiency in Adults (QoL-AGHDA) questionnaire in a general population: results from a French panel study”. Value in Health. 2010.
Humphrey, L., Arbuckle, R., Mease, P., Williams, D.A., Danneskiold-Samsoe, B., Gilbert, C. “Fatigue in fibromyalgia: a conceptual model informed by patient interviews”. BMC Musculoskelet Disord. 2010;11:216.
Ito, D., Stokes, J., Piault, E., Bonnet, P. “Caregiver burden in Alzheimer's disease”. 2010.
Jansen, J. “Adjusted indirect treatment comparison of survival curves. An example with multiple myeloma treatments”. 2010.
Jansen, J., Gaugris, S., Choy, E., Ostor, A., Nash, J.T., Stam, W. “Cost effectiveness of Etoricoxib versus Celecoxib and non-selective NSAIDS in the treatment on Ankylosing Spondylitis”. PharmacoEconomics. 2010;28:323-344.
Jansen, J. “When are indirect treatment comparisons biased? A graphical explanation”. 2010.
Johansen, K.L., Finkelstein, F.O., Revicki, D., Gitlin, M., Evans, C., Mayne, T. “Systematic Review and Meta-analysis of Exercise Tolerance and Physical Functioning in Dialysis Patients Treated with Erythropoiesis-Stimulating Agents”. Am J Kidney Dis. 2010;55:535-548
Kopp, Z., Evans, C., Brubaker, L. “PRO questionnaires to screen and measure satisfaction, expectations, and goal achievement”. In: Cardoz, L., Staskin, D., eds. Female Urology and Urogynecology. London: Informa Healthcare; 2010:114-123.
Lasch, K., Stokes, J., Liepa, A., Meldahl, M., Arnett, L., Basch, E. “Drivers of treatment decision following first-line therapy in advanced non-small cell lung cancer”. 2010.
Lasch, K., Marquis, P., Vigneux, M., Abetz, L., Arnould, B., Bayliss, M., et al. “PRO development: rigorous qualitative research as the crucial foundation”. Qual Life Res. 2010.
McGrath, C., Rofail, D., Gargon, E., Abetz, L. “Using qualitative methods to inform the trade-off between content validity and consistency in utility assessment: the example of type 2 diabetes and Alzheimer's disease”. Health Qual Life Outcomes. 2010;8:23.
Ng-Mak, D.S., Fitzgerald, K., Norquist, J.M., Banderas, B., Nelsen, L.M., Evans, C., et al. “Key concepts of migraine postdrome: A qualitative study to develop a post-migraine questionnaire”. Headache. 2010;105-117.
Nordmann, J.P., Baudouin, C., Renard, J.P., Denis, P., Regnault, A., Berdeaux, G. “Identification of non-compliant glaucoma patients using bayesian networks and the eye-drop satisfaction questionnaire”. Clinical Ophthalmology. 2010.
Pearson, J., Wenzel, K., Burke, L., Scott, J., Trentacosti, A., Papadopoulos, E., et al. “SIAC report from "Measuring Study Endpoints in Multinational Clinical Trials: Outcomes Reported from the Viewpoint of the Clinician, Patient and Caregiver". DIA Global Forum. 2010;2:91-93.
Philips, Z. “Cost-effectiveness of shared pharmaceutical care for older patients: RESPECT trial findings”. Br J Gen Pract. 2010;60:e20-e27.
Philips, Z. “Effectiveness of shared pharmaceutical care for older patients: RESPECT trial findings”. Br J Gen Pract. 2010;60:e10-e19.
Regnault, A., Viala-Danten, M., Gilet, H., Berdeaux, G. “Scoring and psychometric properties of the Eye-Drop Satisfaction Questionnaire (EDSQ), an instrument to assess satisfaction and compliance with glaucoma treatment”. BMC Ophthalmol. 2010;10:1.:1.
Reygrobellet, C., Viala-Danten, M., Meunier, J., Weber, F., Nguyen, V.H. “Perception and acceptance of intradermal influenza vaccination: Patient reported outcomes from phase 3 clinical trials”. Hum Vaccin. 2010;6.
Rofail, D., Viala, M., Gater, A., Abetz-Webb, L., Baladi, J.F., Cappellini, M.D. “An instrument assessing satisfaction with iron chelation therapy: Psychometric testing from an open-label clinical trial”. Adv Ther. 2010;27:533-546.
Silverman, S., Sadosky, A., Evans, C., Yeh, Y., Alvir, J., Zlateva, G. “Toward characterization and definition of fibromyalgia severity”. aher, A., Al Jefri, A., Elalfy, M.S., Al Zir, K., Daar, S., Rofail, D., et al. “Improved treatment satisfaction and convenience with deferasirox in iron-overloaded patients with beta-Thalassemia: Results from the ESCALATOR Trial”. Acta Haematol. 2010;123:220-225.
van Eerd, M.C., Mario Ouwens, J.N., de Peuter, M.A. “Cost-effectiveness study comparing pharmaceutically licensed plasma for transfusion (OctaplasLG(R)) versus fresh frozen plasma (FFP) in critically Ill patients in the UK”. Transfus Apher Sci. 2010;43:251-259.
Verdian, L., Yi, Y. “Cost-utility analysis of rufinamide versus topiramate and lamotrigine for the treatment of children with Lennox-Gastaut Syndrome in the United Kingdom”. Seizure. 2010;19:1-11.
Viala-Danten, M., Dubois, D., Gilet, H., Martin, S., Peeters, K., Cella, D. “Psychometric evaluation of the Functional Assessment of HIV Infection (FAHI) questionnaire and its usefulness in clinical trials”. Quality of Life Research. 2010.
Vissers, D., Stam, W., Nolte, T., Lenre, M., Jansen, J. “Efficacy of intranasal fentanyl spray versus other opioids for breakthrough pain in cancer”. Curr Med Res Opin. 2010.
Vissers, D., Nolte, T., Lenre, M., Jansen, J. “Efficacy of intranasal fentanyl spray versus other opioids for breakthrough pain in cancer”. Current Medical Research and Opinion. 2010;26:1037-1045.
Yi, Y., Philips, Z., Bergman, G., Burslem,K. “Economic models in type 2 diabetes”. Curr Med Res Opin. 2010;26:2105-2118.
Zlateva, G., Diazaraque, R., Viala-Danten, M., Niculescu, L. “Burden of anemia in patients with osteoarthritis and rheumatoid arthritis in French secondary care”. BMC Geriatrics. 2010;10.
Anfray, C., Dulac Trimoreau, M. “New Questionnaires distributed by MAPI Research Trust”. Patient Reported Outcomes Newsletter. Spring Issue 2010:43:9-10.
Conway, K., Patrick, D., Gauchon, T., Acquadro, C. “Enhancing Cross-Cultural Appropriateness for Newly Developed Patient-Reported Outcome (PRO) Instruments: the Use of Translatability Assessment”. Patient Reported Outcomes Newsletter. Fall Issue 2010:44:9-12.
Ito, DSJP-LEL-MJ. “Development of a Caregiver Burden Assessment in Alzheimer's Disease”. 4 January 2010.
Le Gal, M., , Mainguy, Y., Le Lay, K., Nadjar, A., Allain, D., Galissié, M. “Linguistic validation of six patient-reported outcomes instruments into 12 languages for patients with fibromyalgia”. Joint Bone Spine. 2010 March;77(2):165-1.